Maximum Strength Moisture Barrier Ointment
NDC Package 64772-203-01
Package Information
Maximum Strength Moisture Barrier (petrolatum and zinc oxide) ointment is usesTemporarily protects and helps relieve minor skin irritation and itching due to rashes. This formulation utilizes a ointment delivery system. Marketed by Derma Sciences Canada Inc., this product is identified by NDC 64772-203 and is authorized under FDA application M016.
Identification & Billing
- RxCUI: 2727316 - petrolatum 50 % / zinc oxide 16 % Topical Ointment
- RxCUI: 2727316 - petrolatum 0.5 MG/MG / zinc oxide 0.16 MG/MG Topical Ointment
- RxCUI: 2727316 - petrolatum 0.5 MG/MG / ZNO 0.16 MG/MG Topical Ointment
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 64772 - Derma Sciences Canada Inc.
- 64772-203 - Maximum Strength Moisture Barrier
- 64772-203-01 - 113.4 g in 1 TUBE
- 64772-203 - Maximum Strength Moisture Barrier
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 64772-203-01 identifies a specific commercial package of 113.4 g in 1 tube of Maximum Strength Moisture Barrier, a human over the counter drug labeled by Derma Sciences Canada Inc.. This ointment is formulated for topical use and contains petrolatum; zinc oxide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Derma Sciences Canada Inc. on November 13, 2014. The current certification is valid through December 31, 2026.
How is this Derma Sciences Canada Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 64772020301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.